J.P. Morgan: BenevolentAI Aims To Stay Ahead Of The Chasing Pack

 
• By Kevin Grogan

The UK firm's platform has been validated by the partnerships sealed with AstraZeneca and Merck KGaA and the development of an internal five-strong product pipeline, acting CEO Francois Nader told attendees at the J.P. Morgan Healthcare Conference.    

Benevolent
• Source: BenevolentAI

More from AI

More from Conferences